Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 1828

Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 3603

Carnival Corporation (NYSE:CCL), Royal Caribbean (RCL) could climb 20%

By Arthur Greene December 15, 2014
Warning: A non-numeric value encountered in /home2/sharonox/public_html/wp-content/themes/allegro-theme-child/functions/other.php on line 93
Carnival Corporation (NYSE:CCL) and Royal Caribbean could climb 20%, Barron's says. According to an analysis in Barron's, Carnival Corporation (CCL) and Royal Caribbean (RCL) could both climb 20%. This increase is expected to be driven by growing demand.  The paper also discussed Norwegian Cruise Line (NCLH)  and said that NCLH looks reasonably priced.  Carnival Corporation (NYSE:CCL) is part of the Services sector in Resorts & Casinos industry and operates as a cruise company worldwide. The stock closed for the day at 42.95 with a change of 0.58 or 1.33%%. CCL opened at 43.75 and traded with a volume of 4,810,044 shares.

 

FMC Corp. (NYSE: FMC) could see a rally of rally 50%, according to Barron's.  In this article, Barron's  says that chemicals maker FMC Corporation shares could see a 50% increase to reach around $85.00 per share in the next couple of years. This rally is expected to be fuelled by expanding margins. FMC Corporation is a diversified chemical company that provides applications, solutions, and products for industrial, environmental, agricultural and consumer markets.  FMC Corp. (NYSE: FMC) traded in the red and closed at 55.00 for the day. The stock saw a change 0.82 (1.47%) with a volume of 1,887,092 shares. FMC has a market cap of 7.33B.

 

Theravance Biopharma, Inc. (Nasdaq:TBPH) sees FY15 operating loss ($160M)-($150M). It is much higher than the Street’s  consensus  of a loss of ($6.83). This loss is excluding stock-based compensation. Theravance Biopharma, Inc.is likely to be front-loaded.  Analysts see FY15 VIBATIV net sales to be approximately $20M.  Theravance Biopharma, Inc., a biopharmaceutical company, that focuses on the discovery, development, and commercialization of small molecule medicines. The closing for TBPH  was at 13.91 at the day’s end. It was a change of 0.10. TBPH  saw an intra day volume of 337,487 shares and a market cap of 448.29M.

Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 1828

Deprecated: Function get_magic_quotes_gpc() is deprecated in /home2/sharonox/public_html/wp-includes/formatting.php on line 3603
By Arthur Greene December 15, 2014
Warning: A non-numeric value encountered in /home2/sharonox/public_html/wp-content/themes/allegro-theme-child/functions/other.php on line 93

Latest from MarketsDaily